These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8961067)

  • 1. Pharmacokinetics of netivudine in haemodialysis patients.
    Le Roy F; Godin M; Legallicler B; Fillastre JP; Bidault R; Posner J; Peck RW
    J Antimicrob Chemother; 1996 Nov; 38(5):913-5. PubMed ID: 8961067
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairment.
    Fillastre JP; Godin M; Legallicier B; Chretien P; Bidault R; Gillotin C; Wooton R; Posner J; Peck RW
    J Antimicrob Chemother; 1996 May; 37(5):965-74. PubMed ID: 8737146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.
    Peck RW; Crome P; Wood MJ; McKendrick MW; Bannister B; Mandal BK; Crooks RJ
    J Antimicrob Chemother; 1996 Mar; 37(3):583-97. PubMed ID: 9182115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dihydropyrimidine dehydrogenase by 5-propynyluracil, a metabolite of the anti-varicella zoster virus agent netivudine.
    Peck R; Wiggs R; Callaghan J; Wootton R; Crome P; Fraser I; Frick L; Posner J
    Clin Pharmacol Ther; 1996 Jan; 59(1):22-31. PubMed ID: 8549030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats.
    Wright JD; Ma T; Chu CK; Boudinot FD
    Pharm Res; 1995 Sep; 12(9):1350-3. PubMed ID: 8570534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19F NMR study of the uptake of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil in erythrocytes: evidence of transport by facilitated and nonfacilitated pathways.
    Xu AS; Chu CK; London RE
    Biochem Pharmacol; 1998 May; 55(10):1611-9. PubMed ID: 9633997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
    Bading JR; Shahinian AH; Bathija P; Conti PS
    Nucl Med Biol; 2000 May; 27(4):361-8. PubMed ID: 10938471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
    Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
    Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Jagoda E; Ogan M; Stouffer B; Tsay HM; Turabi N; Mantha S; Yost F; Tu JI
    Ther Drug Monit; 1992 Dec; 14(6):499-508. PubMed ID: 1485373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group.
    Söltz-Szöts J; Tyring S; Andersen PL; Lucht RF; McKendrick MW; Diaz Perez JL; Shukla S; Fiddian AP
    J Antimicrob Chemother; 1998 May; 41(5):549-56. PubMed ID: 9630408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus.
    Shouval D
    J Hepatol; 2010 Aug; 53(2):219-20. PubMed ID: 20579760
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents.
    McGuigan C; Perry A; Yarnold CJ; Sutton PW; Lowe D; Miller W; Rahim SG; Slater MJ
    Antivir Chem Chemother; 1998 May; 9(3):233-43. PubMed ID: 9875402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment.
    Swan SK; Smith WB; Marbury TC; Schumacher M; Dougherty C; Mico BA; Villano SA
    J Clin Pharmacol; 2007 Feb; 47(2):209-17. PubMed ID: 17244772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of azlocillin in impaired renal function and haemodialysis (author's transl)].
    Schurig R; Kampf D; Becker H; Förster D
    Arzneimittelforschung; 1979; 29(12a):1944-8. PubMed ID: 543896
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study.
    Kawakami Y; Imamura M; Ikeda H; Suzuki M; Arataki K; Moriishi M; Mori N; Kokoroishi K; Katamura Y; Ezaki T; Ueno T; Ide K; Masaki T; Ohdan H; Chayama K
    J Viral Hepat; 2016 Nov; 23(11):850-856. PubMed ID: 27346670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent.
    Peck RW; Wootton R; Lee DR; Jackson SH; Posner J
    Br J Clin Pharmacol; 1995 Feb; 39(2):143-9. PubMed ID: 7742152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.
    Shuster DL; Menon RM; Ding B; Khatri A; Li H; Cohen E; Jewett M; Cohen DE; Zha J
    Eur J Clin Pharmacol; 2019 Feb; 75(2):207-216. PubMed ID: 30291369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
    Gartenberg G; Meyers BR; Hirschmann SZ; Srulevitch E
    J Antimicrob Chemother; 1979 Jul; 5(4):465-70. PubMed ID: 489494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug usage in dialysis patients].
    Kawaguchi Y; Yamamoto H
    Nihon Rinsho; 1992 Jan; 50 Suppl():651-62. PubMed ID: 1578749
    [No Abstract]   [Full Text] [Related]  

  • 20. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Nishiyama T; Ogura K; Nagayama S; Ikeda K; Yamaguchi S; Nakamura Y; Kawaguchi K; Watabe T; Ogura Y
    Drug Metab Dispos; 1997 Feb; 25(2):270-3. PubMed ID: 9029059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.